Profil
Moritz Greve is the founder of Maxburg Capital Partners GmbH, which was founded in 2014.
He held the title of Partner at the firm.
He is currently a Member-Supervisory Board at PharmaZell GmbH.
Mr. Greve was also a Member-Supervisory Board at zooplus SE from 2014 to 2016.
He has an undergraduate and graduate degree from ESCP Europe and an MBA from INSEAD, which he received in 2009.
Aktive Positionen von Moritz Greve
| Unternehmen | Position | Beginn |
|---|---|---|
Maxburg Capital Partners GmbH
Maxburg Capital Partners GmbH Investment ManagersFinance Maxburg Capital Partners invests in small and mid-sized companies located in the Germany and the German-speaking markets. The firm targets companies operating in the fields of FMCG, light industries & manufacturing, internet & services, TMT as well as healthcare sectors. It provides equity and mezzanine financing for buyouts, MBOs, MBIs, spin-offs, carve-outs, PIPE (Private Investment in Public Equity), public-to-private transactions, and growth capital requirements with an investment size between EUR 10 and EUR 100 million per transaction. It acquires minority & majority position and also makes co-investments. | Gründer | 01.01.2014 |
PharmaZell GmbH
PharmaZell GmbH BiotechnologyHealth Technology Engages in development and manufacturing of pharmaceutical ingredients | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Moritz Greve
| Unternehmen | Position | Ende |
|---|---|---|
| ZOOPLUS SE | Direktor/Vorstandsmitglied | - |
Ausbildung von Moritz Greve
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
zooplus SE
zooplus SE Specialty StoresRetail Trade Sells pet food and accessories and operates mobile app | Retail Trade |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaZell GmbH
PharmaZell GmbH BiotechnologyHealth Technology Engages in development and manufacturing of pharmaceutical ingredients | Health Technology |
Maxburg Capital Partners GmbH
Maxburg Capital Partners GmbH Investment ManagersFinance Maxburg Capital Partners invests in small and mid-sized companies located in the Germany and the German-speaking markets. The firm targets companies operating in the fields of FMCG, light industries & manufacturing, internet & services, TMT as well as healthcare sectors. It provides equity and mezzanine financing for buyouts, MBOs, MBIs, spin-offs, carve-outs, PIPE (Private Investment in Public Equity), public-to-private transactions, and growth capital requirements with an investment size between EUR 10 and EUR 100 million per transaction. It acquires minority & majority position and also makes co-investments. | Finance |
ESCP Europe
ESCP Europe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















